Due to limited tumor samples, the CD8+ T‐cell assessment by flow cytometry did not reach statistical significance (p = 0.2, for Control vs. APG‐157 + anti‐CTLA‐4, Figure 3B). The gene discussed is CD8A; the disease is neoplasm.